STOCK TITAN

Notifications

Limited Time Offer! Get Platinum at the Gold price until January 31, 2026!

Sign up now and unlock all premium features at an incredible discount.

Read more on the Pricing page

  1. Home
  2. News
  3. ERPY
  4. Rapport Financier Semestriel 30 Juin 2023 PHAXIAM

Rapport Financier Semestriel 30 Juin 2023 PHAXIAM

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags

Rapport Financier Semestriel 30 Juin 2023 PHAXIAM

Attachment


Stock ERPY logo
ERPY

:ERPY

ERPY Rankings

N/A Ranked by Market Cap
N/A Ranked by Dividends

ERPY Latest News

Oct 9, 2023
PHAXIAM Therapeutics announces high coverage performance of its two anti-Staphylococcus aureus phages over clinical strains
Oct 4, 2023
PHAXIAM Receives Compliance Notice from Nasdaq
Oct 3, 2023
PHAXIAM Therapeutics and Vetophage Announce Strategic Research Collaboration
Sep 21, 2023
PHAXIAM Provides Business and Financial Update For the First Half of 2023
Sep 19, 2023
PHAXIAM Therapeutics extends its phage portfolio to Klebsiella pneumoniae, a new resistant and aggressive bacterial target

ERPY Stock Data

Related Articles

Continue reading with these related stories

View All Latest News